SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-003611
Filing Date
2011-01-19
Accepted
2011-01-19 08:09:36
Documents
7
Period of Report
2011-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K b84367e8vk.htm 8-K 19660
2 EX-4.1 b84367exv4w1.htm EX-4.1 83228
3 EX-10.1 b84367exv10w1.htm EX-10.1 62095
4 EX-10.2 b84367exv10w2.htm EX-10.2 19236
5 EX-10.3 b84367exv10w3.htm EX-10.3 8239
6 EX-99.1 b84367exv99w1.htm EX-99.1 6625
7 GRAPHIC b84367b8436701.gif GRAPHIC 4891
  Complete submission text file 0000950123-11-003611.txt   207555
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 11534490
SIC: 2836 Biological Products, (No Diagnostic Substances)